Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial “concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma”: Individual case review analysis-Reference-Cited by-同舟云学术

Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial “concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma”: Individual case review analysis

Published:2018-05 Issue:2 Volume:127 Page:292-298
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Abrunhosa-Branquinho André N.,Bar-Deroma Raquel,Collette Sandra,Clementel Enrico,Liu Yan,Hurkmans Coen W.,Feuvret Loïc,Van Beek Karen,van den Bent Martin,Baumert Brigitta G.,Weber Damien C.

Funder

Fonds Cancer

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference24 articles.

1. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group;Kristiansen;Cancer,1981

2. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial;Walker;J Neurosurg,1978

3. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review;Laperriere;Radiother Oncol,2002

4. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402;Cairncross;J Clin Oncol,2013

5. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951;van den Bent;J Clin Oncol,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiotherapy trial quality assurance processes: a systematic review;The Lancet Oncology;2024-03

2. The influence of anisotropy on the clinical target volume of brain tumor patients;Physics in Medicine & Biology;2024-01-19

3. TEMPORARY REMOVAL: Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for radiotherapy and Oncology (ESTRO);Radiotherapy and Oncology;2023-12

4. Optimising of axillary therapy in breast cancer: lessons from the past to plan for a better future;La radiologia medica;2023-11-03

5. Deep-learning magnetic resonance imaging-based automatic segmentation for organs-at-risk in the brain: Accuracy and impact on dose distribution;Physics and Imaging in Radiation Oncology;2023-07